Literature DB >> 19430716

The loss of HBeAg without precore mutation results in lower HBV DNA levels and ALT levels in chronic hepatitis B virus infection.

Naoto Kawabe1, Senju Hashimoto, Masao Harata, Yoshifumi Nitta, Michihito Murao, Takuji Nakano, Hiroaki Shimazaki, Yuko Arima, Naruomi Komura, Kyoko Kobayashi, Kentaro Yoshioka.   

Abstract

BACKGROUND: The aim of this study was to investigate the correlation between precore (PC)/basal core promoter (BCP) mutations and the viral loads or activity of hepatitis in patients with chronic hepatitis B virus (HBV) infection.
METHODS: HBV genotypes, PC mutations, BCP mutations, HBV DNA levels, and serological markers of HBV were analyzed in all the patients with chronic HBV infection seen in Fujita Health University Hospital from June 2004 to November 2008 (n=215).
RESULTS: HBV genotype was C in 169 patients, B in 16, A in 3, F in 1, and unclassifiable in 5. Among the patients with genotype C, the prevalence of PC wild type was significantly lower in hepatitis B envelope antigen (HBeAg)(-) patients than in HBeAg(+) patients (9.5% versus 49.0%, P<0.0001). Among HBeAg(-) patients, the patients with PC wild type had significantly lower serum viral loads and alanine aminotransferase (ALT) levels compared with those with PC mutant (P<0.001). Among HBeAg(-) patients, the patients with genotype B had lower serum viral loads compared with those with genotype C (3.6+/-0.9 versus 4.6+/-1.6, P<0.05), and the prevalence of BCP wild type was significantly higher in those with genotype B than in those with genotype C (58.3% versus 10.8%, P<0.05).
CONCLUSIONS: Among HBeAg(-) patients with genotype C, the patients with PC wild type had significantly lower viral loads and ALT levels than those with PC mutant. This suggests that the patients with PC wild type may have better prognosis than those with PC mutant among HBeAg(-) patients with genotype C.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430716     DOI: 10.1007/s00535-009-0061-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  29 in total

1.  A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group.

Authors:  E Orito; M Mizokami; H Sakugawa; K Michitaka; K Ishikawa; T Ichida; T Okanoue; H Yotsuyanagi; S Iino
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

Review 2.  Hepatitis B virus infection--natural history and clinical consequences.

Authors:  Don Ganem; Alfred M Prince
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

3.  Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea.

Authors:  Byung Chul Yoo; Joong-Won Park; Hyung Joon Kim; Dong Ho Lee; Young Ju Cha; Sill Moo Park
Journal:  J Hepatol       Date:  2003-01       Impact factor: 25.083

4.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

5.  Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.

Authors:  Chien-Hung Chen; Chuan-Mo Lee; Sheng-Nan Lu; Chi-Sin Changchien; Hock-Liew Eng; Chao-Min Huang; Jing-Houng Wang; Chao-Hung Hung; Tsung-Hui Hu
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

6.  Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan.

Authors:  E Orito; T Ichida; H Sakugawa; M Sata; N Horiike; K Hino; K Okita; T Okanoue; S Iino; E Tanaka; K Suzuki; H Watanabe; S Hige; M Mizokami
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

7.  Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.

Authors:  M Lindh; P Horal; A P Dhillon; G Norkrans
Journal:  J Viral Hepat       Date:  2000-07       Impact factor: 3.728

8.  Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.

Authors:  Ingolf Schiefke; Chris Klecker; Melanie Maier; Ute Oesen; Gunnar Etzrodt; Andrea Tannapfel; Uwe G Liebert; Frieder Berr
Journal:  Liver Int       Date:  2004-04       Impact factor: 5.828

9.  The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection.

Authors:  K Takahashi; K Aoyama; N Ohno; K Iwata; Y Akahane; K Baba; H Yoshizawa; S Mishiro
Journal:  J Gen Virol       Date:  1995-12       Impact factor: 3.891

10.  Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan.

Authors:  Fuminaka Sugauchi; Hiromitsu Kumada; Hiroshi Sakugawa; Masafumi Komatsu; Hirofumi Niitsuma; Hisayoshi Watanabe; Yoshihiro Akahane; Hajime Tokita; Takanobu Kato; Yasuhito Tanaka; Etsuro Orito; Ryuzo Ueda; Yuzo Miyakawa; Masashi Mizokami
Journal:  Clin Infect Dis       Date:  2004-04-09       Impact factor: 9.079

View more
  4 in total

1.  Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.

Authors:  Nozomi Kamijo; Akihiro Matsumoto; Takeji Umemura; Soichiro Shibata; Yuki Ichikawa; Takefumi Kimura; Michiharu Komatsu; Eiji Tanaka
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 2.  Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.

Authors:  Francisco Rodriguez-Frias; Maria Buti; David Tabernero; Maria Homs
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

3.  Molecular characterization of hepatitis B virus X gene in chronic hepatitis B patients.

Authors:  Luciana Barbini; Luciana Tadey; Silvina Fernandez; Belen Bouzas; Rodolfo Campos
Journal:  Virol J       Date:  2012-07-08       Impact factor: 4.099

4.  Hepatitis B virus genotypes and evolutionary profiles from blood donors from the northwest region of China.

Authors:  Xing-Bin Hu; Qiao-Hong Yue; Xian-Qing Zhang; Xue-Qing Xu; Yin Wen; Yao-Zhen Chen; Xiao-Dong Cheng; Liu Yang; Shi-Jie Mu
Journal:  Virol J       Date:  2009-11-17       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.